Dietary Supplements Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Dietary Supplements Market
The dietary supplements market size was valued at USD 61.20 billion in 2020, and the market is now projected to grow from USD 71.81 billion in 2021 to USD 128.64 billion in 2028, exhibiting a CAGR of 8.68% during the forecast period of 2021-2028.
The COVID-19 pandemic created significant opportunities on the dietary supplements market growth as curbing coronavirus outbreak was prioritized. The abrupt flare-up of the Covid pandemic has decidedly affected the market development. The drawn-out implications are still difficult to gauge, as the worldwide economy is battling with this pandemic circumstance, and it can influence the worldwide exchange and supply chain of dietary supplements products. Be that as it may, the popularity for human food supplements in created as well as creating locales, since they give areas of strength for a capability and lessen the chance of wellbeing dangers, is supposed to emphatically use the item development all through the estimate period.
The dietary supplements market share globally has been contributed due to the preventive medical services measures. With the rising predominance old enough and way of life related infections, customers are turning out to be progressively aware of preventive medical care measures. They subsequently are leaning towards wellbeing helping items, for example, food added substances, as most would consider to be normal to drive the worldwide market. Expanding development by key as well as little market players is further enlarging the development of the market at the worldwide level. For example, in Walk 2018, The GHT organizations declared the sendoff of another product offering of 100 percent vegetarian nutritive. The new items are fabricated to satisfy the rising need for creature free plant-based items that help weight the board.
Furthermore, there’s been a notable trend Interest for customized supplements. Rising mindfulness about the idea of customized or custom healthful items and dietary supplements has lighted the premium of purchasers across various pieces of the globe and is influencing the development of the dietary added substances market emphatically. Mechanical progressions and expanded interest in the examination and advancement of nutraceuticals and supplement items are supposed further to support the market development in the impending years. For example, in January 2019, Settle S.A. opened its most memorable Research and development focus in Ireland with a speculation of USD 31.46 million. The new Research and development focus will zero in on logical examination to help oddities in creating baby sustenance items and milk-based materials for the worldwide market.
Comprehensive Dietary Supplements Market
Dietary supplements are characterized as items that contain somewhere around one dietary fixing and can be consumed orally. The rising ubiquity of sports-based and athletic execution upgrade supplements drives the worldwide market. The arising customer needs to address day to day necessities of micronutrients in the body, and expanded shopper spending on wellbeing and health items is supposed to fuel the dietary supplements market. Besides, drives taken by a few legislatures to help the creation of natural enhancements are supposed to emphatically influence market development. For example, in July 2020, the Indian government reported a monetary boost bundle under the Atmanirbhar Bharat Abhiyan and distributed USD 535 million to the natural area to advance home grown development.
The Asia Pacific worldwide market will enroll the quickest build yearly development pace of 9.02% during 2021-2028 attributable to the rising wellbeing cognizance among buyers, which is spurring them to embrace wellbeing improving enhancement items in their day-to-day routine. The interest for dietary enhancements is expanding at a quick speed in exceptionally populated nations of the district, like China and India. The rising mindfulness about the idea of customized nourishment is anticipated to improve the buyer base for dietary supplements across the region. Besides, expanded revenue of key global market players in extending their creation bases and item portfolio across Asian and Southeast Asian nations like South Korea, Malaysia, India, China, and others because of high populace thickness is expected to give a lift to the local market development.
The top players in the market play a crucial role in the dietary supplements market assuring industrial prospectus growth and setting market standards. These players include, Amway Corp (Michigan, U.S.), Abbott (Illinois, U.S.), Nestle S.A. (Vevey, Switzerland), Herbalife Nutrition Ltd. (California, U.S.) and Archer Daniels Midland Company (Illinois, U.S.) these market players provide a level-playing competitive landscape.
In April 2021, Persona Nutrition, a conspicuous customized nutrient program, reported the sendoff of the globe's most memorable everyday sticky nutrient packs for the entire family. These nutrient packs are intended to address different wellbeing objectives, including unwinding, resistant wellbeing, skin wellbeing, center upgrade, and regular wellbeing support.
Segmentation Table
Dietary supplements Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2021-2028
Growth Rate CAGR of 8.68% from 2024-2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Type, End-User, and Region
By Type Vitamins
Minerals
Enzymes
Fatty Acids
Proteins
Others
By End-User
Tablets
Capsules
Liquids
Powders
By Region North America (By Type, End-User, and Country)
- U.S. (By Type and End-User)
- Canada (By Type and End-User)
Europe (By Type, End-User, and Country/Sub-region)
- U.K. (By Type and End-User)
- Germany (By Type and End-User)
- France (By Type and End-User)
- Italy (By Type and End-User)
- Spain (By Type and End-User)
- Rest of Europe (By Type and End-User)
Asia Pacific (By Type, End-User, and Country/Sub-region)
- China (By Type and End-User)
- Japan (By Type and End-User)
- India (By Type and End-User)
- Australia (By Type and End-User)
- Rest of Asia Pacific (By Type and End-User)
Latin America (By Type, End-User, and Country/Sub-region)
- Brazil (By Type and End-User)
- Mexico (By Type and End-User)
- Rest of Latin America (By Type and End-User)
Middle East & Africa (By Type, End-User, and Country/ Sub-region)
- GCC (By Type and End-User)
- South Africa (By Type and End-User)
- Rest of Middle East & Africa (By Type and End-User)
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Overview of the Parent Market
- 4.2. Industry SWOT Analysis
- 4.3. Supply Chain Analysis
- 4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
- 4.5. Qualitative Analysis (in relation to COVID-19)
- 4.5.1. Impact of COVID-19
- 4.5.2. Supply Chain Challenges
- 4.5.3. Potential Opportunities due to COVID-19
- 5. Global Dietary Supplements Market Analysis, Insights and Forecast, 2017-2028
- 5.1. Key Findings / Summary
- 5.2. Market Size Estimates and Forecast
- 5.2.1. By Type (Value)
- 5.2.1.1. Vitamins
- 5.2.1.2. Minerals
- 5.2.1.3. Enzymes
- 5.2.1.4. Fatty Acids
- 5.2.1.5. Proteins
- 5.2.1.6. Others
- 5.2.2. By Form (Value)
- 5.2.2.1. Tablets
- 5.2.2.2. Capsules
- 5.2.2.3. Liquids
- 5.2.2.4. Powders
- 5.2.3. By Region (Value)
- 5.2.3.1. North America
- 5.2.3.2. Europe
- 5.2.3.3. Asia Pacific
- 5.2.3.4. South America
- 5.2.3.5. Middle East & Africa
- 6. North America Dietary Supplements Market Analysis, Insights and Forecast, 2017-2028
- 6.1. Key Findings / Summary
- 6.2. Market Size Estimates and Forecast
- 6.2.1. By Type (Value)
- 6.2.1.1. Vitamins
- 6.2.1.2. Minerals
- 6.2.1.3. Enzymes
- 6.2.1.4. Fatty Acids
- 6.2.1.5. Proteins
- 6.2.1.6. Others
- 6.2.2. By Form (Value)
- 6.2.2.1. Tablets
- 6.2.2.2. Capsules
- 6.2.2.3. Liquids
- 6.2.2.4. Powders
- 6.2.3. By Country (Value)
- 6.2.3.1. The U.S.
- 6.2.3.1.1. By Form (Value)
- 6.2.3.1.1.1. Tablets
- 6.2.3.1.1.2. Capsules
- 6.2.3.1.1.3. Liquids
- 6.2.3.1.1.4. Powders
- 6.2.3.2. Canada
- 6.2.3.2.1. By Form (Value)
- 6.2.3.2.1.1. Tablets
- 6.2.3.2.1.2. Capsules
- 6.2.3.2.1.3. Liquids
- 6.2.3.2.1.4. Powders
- 6.2.3.3. Mexico
- 6.2.3.3.1. By Form (Value)
- 6.2.3.3.1.1. Tablets
- 6.2.3.3.1.2. Capsules
- 6.2.3.3.1.3. Liquids
- 6.2.3.3.1.4. Powders
- 7. Europe Dietary Supplements Market Analysis, Insights and Forecast, 2017-2028
- 7.1. Key Findings / Summary
- 7.2. Market Size Estimates and Forecast
- 7.2.1. By Type (Value)
- 7.2.1.1. Vitamins
- 7.2.1.2. Minerals
- 7.2.1.3. Enzymes
- 7.2.1.4. Fatty Acids
- 7.2.1.5. Proteins
- 7.2.1.6. Others
- 7.2.2. By Form (Value)
- 7.2.2.1. Tablets
- 7.2.2.2. Capsules
- 7.2.2.3. Liquids
- 7.2.2.4. Powders
- 7.2.3. By Country (Value)
- 7.2.3.1. Germany
- 7.2.3.1.1. By Form (Value)
- 7.2.3.1.1.1. Tablets
- 7.2.3.1.1.2. Capsules
- 7.2.3.1.1.3. Liquids
- 7.2.3.1.1.4. Powders
- 7.2.3.2. France
- 7.2.3.2.1. By Form (Value)
- 7.2.3.2.1.1. Tablets
- 7.2.3.2.1.2. Capsules
- 7.2.3.2.1.3. Liquids
- 7.2.3.2.1.4. Powders
- 7.2.3.3. Italy
- 7.2.3.3.1. By Form (Value)
- 7.2.3.3.1.1. Tablets
- 7.2.3.3.1.2. Capsules
- 7.2.3.3.1.3. Liquids
- 7.2.3.3.1.4. Powders
- 7.2.3.4. Spain
- 7.2.3.4.1. By Form (Value)
- 7.2.3.4.1.1. Tablets
- 7.2.3.4.1.2. Capsules
- 7.2.3.4.1.3. Liquids
- 7.2.3.4.1.4. Powders
- 7.2.3.5. U.K.
- 7.2.3.5.1. By Form (Value)
- 7.2.3.5.1.1. Tablets
- 7.2.3.5.1.2. Capsules
- 7.2.3.5.1.3. Liquids
- 7.2.3.5.1.4. Powders
- 7.2.3.6. Rest of Europe
- 7.2.3.6.1. By Form (Value)
- 7.2.3.6.1.1. Tablets
- 7.2.3.6.1.2. Capsules
- 7.2.3.6.1.3. Liquids
- 7.2.3.6.1.4. Powders
- 8. Asia-Pacific Dietary Supplements MarketAnalysis, Insights and Forecast, 2017-2028
- 8.1. Key Findings / Summary
- 8.2. Market Size Estimates and Forecast
- 8.2.1. By Type (Value)
- 8.2.1.1. Vitamins
- 8.2.1.2. Minerals
- 8.2.1.3. Enzymes
- 8.2.1.4. Fatty Acids
- 8.2.1.5. Proteins
- 8.2.1.6. Others
- 8.2.2. By Form (Value)
- 8.2.2.1. Tablets
- 8.2.2.2. Capsules
- 8.2.2.3. Liquids
- 8.2.2.4. Powders
- 8.2.3. By Country (Value)
- 8.2.3.1. China
- 8.2.3.1.1. By Form (Value)
- 8.2.3.1.1.1. Tablets
- 8.2.3.1.1.2. Capsules
- 8.2.3.1.1.3. Liquids
- 8.2.3.1.1.4. Powders
- 8.2.3.2. India
- 8.2.3.2.1. By Form (Value)
- 8.2.3.2.1.1. Tablets
- 8.2.3.2.1.2. Capsules
- 8.2.3.2.1.3. Liquids
- 8.2.3.2.1.4. Powders
- 8.2.3.3. Japan
- 8.2.3.3.1. By Form (Value)
- 8.2.3.3.1.1. Tablets
- 8.2.3.3.1.2. Capsules
- 8.2.3.3.1.3. Liquids
- 8.2.3.3.1.4. Powders
- 8.2.3.4. Australia
- 8.2.3.4.1. By Form (Value)
- 8.2.3.4.1.1. Tablets
- 8.2.3.4.1.2. Capsules
- 8.2.3.4.1.3. Liquids
- 8.2.3.4.1.4. Powders
- 8.2.3.5. Rest of APAC
- 8.2.3.5.1. By Form (Value)
- 8.2.3.5.1.1. Tablets
- 8.2.3.5.1.2. Capsules
- 8.2.3.5.1.3. Liquids
- 8.2.3.5.1.4. Powders
- 9. South America Dietary Supplements MarketAnalysis, Insights and Forecast, 2017-2028
- 9.1. Key Findings / Summary
- 9.2. Market Size Estimates and Forecast
- 9.2.1. By Type (Value)
- 9.2.1.1. Vitamins
- 9.2.1.2. Minerals
- 9.2.1.3. Enzymes
- 9.2.1.4. Fatty Acids
- 9.2.1.5. Proteins
- 9.2.1.6. Others
- 9.2.2. By Form (Value)
- 9.2.2.1. Tablets
- 9.2.2.2. Capsules
- 9.2.2.3. Liquids
- 9.2.2.4. Powders
- 9.2.3. By Country (Value)
- 9.2.3.1. Brazil
- 9.2.3.1.1. By Form (Value)
- 9.2.3.1.1.1. Tablets
- 9.2.3.1.1.2. Capsules
- 9.2.3.1.1.3. Liquids
- 9.2.3.1.1.4. Powders
- 9.2.3.2. Argentina
- 9.2.3.2.1. By Form (Value)
- 9.2.3.2.1.1. Tablets
- 9.2.3.2.1.2. Capsules
- 9.2.3.2.1.3. Liquids
- 9.2.3.2.1.4. Powders
- 9.2.3.3. Rest of South America
- 9.2.3.3.1. By Form (Value)
- 9.2.3.3.1.1. Tablets
- 9.2.3.3.1.2. Capsules
- 9.2.3.3.1.3. Liquids
- 9.2.3.3.1.4. Powders
- 10. Middle East & Africa Dietary Supplements MarketAnalysis, Insights and Forecast, 2017-2028
- 10.1. Key Findings / Summary
- 10.2. Market Size Estimates and Forecast
- 10.2.1. By Type (Value)
- 10.2.1.1. Vitamins
- 10.2.1.2. Minerals
- 10.2.1.3. Enzymes
- 10.2.1.4. Fatty Acids
- 10.2.1.5. Proteins
- 10.2.1.6. Others
- 10.2.2. By Form (Value)
- 10.2.2.1. Tablets
- 10.2.2.2. Capsules
- 10.2.2.3. Liquids
- 10.2.2.4. Powders
- 10.2.3. By Country (Value)
- 10.2.3.1. UAE
- 10.2.3.1.1. By Form (Value)
- 10.2.3.1.1.1. Tablets
- 10.2.3.1.1.2. Capsules
- 10.2.3.1.1.3. Liquids
- 10.2.3.1.1.4. Powders
- 10.2.3.2. South Africa
- 10.2.3.2.1. By Form (Value)
- 10.2.3.2.1.1. Tablets
- 10.2.3.2.1.2. Capsules
- 10.2.3.2.1.3. Liquids
- 10.2.3.2.1.4. Powders
- 10.2.3.3. Rest of ME&A
- 10.2.3.3.1. By Form (Value)
- 10.2.3.3.1.1. Tablets
- 10.2.3.3.1.2. Capsules
- 10.2.3.3.1.3. Liquids
- 10.2.3.3.1.4. Powders
- 11. Competitive Matrix
- 11.1. Key Industry Developments
- 11.2. Global Market Share/Ranking Analysis
- 12. Company Profiles
- 12.1. Amway Corp.
- 12.1.1. Overview
- 12.1.2. Description
- 12.1.3. Species Portfolio
- 12.1.4. Financials (Data as available in public domain and/or on paid databases)
- 12.1.5. Recent Developments
- 12.2. Abbott
- 12.2.1. Overview
- 12.2.2. Description
- 12.2.3. Species Portfolio
- 12.2.4. Financials (Data as available in public domain and/or on paid databases)
- 12.2.5. Recent Developments
- 12.3. Nestle S.A.
- 12.3.1. Overview
- 12.3.2. Description
- 12.3.3. Species Portfolio
- 12.3.4. Financials (Data as available in public domain and/or on paid databases)
- 12.3.5. Recent Developments
- 12.4. Herbalife Nutrition Ltd.
- 12.4.1. Overview
- 12.4.2. Description
- 12.4.3. Species Portfolio
- 12.4.4. Financials (Data as available in public domain and/or on paid databases)
- 12.4.5. Recent Developments
- 12.5. Archer Daniels Midland Company
- 12.5.1. Overview
- 12.5.2. Description
- 12.5.3. Species Portfolio
- 12.5.4. Financials (Data as available in public domain and/or on paid databases)
- 12.5.5. Recent Developments
- 12.6. Glanbia Nutritionals
- 12.6.1. Overview
- 12.6.2. Description
- 12.6.3. Species Portfolio
- 12.6.4. Financials (Data as available in public domain and/or on paid databases)
- 12.6.5. Recent Developments
- 12.7. Otsuka Holdings Co. Ltd.
- 12.7.1. Overview
- 12.7.2. Description
- 12.7.3. Species Portfolio
- 12.7.4. Financials (Data as available in public domain and/or on paid databases)
- 12.7.5. Recent Developments
- 12.8. Arkopharma
- 12.8.1. Overview
- 12.8.2. Description
- 12.8.3. Species Portfolio
- 12.8.4. Financials (Data as available in public domain and/or on paid databases)
- 12.8.5. Recent Developments
- 12.9. Pfizer Inc.
- 12.9.1. Overview
- 12.9.2. Description
- 12.9.3. Species Portfolio
- 12.9.4. Financials (Data as available in public domain and/or on paid databases)
- 12.9.5. Recent Developments
- 12.10. GlaxoSmithKline plc.
- 12.10.1. Overview
- 12.10.2. Description
- 12.10.3. Species Portfolio
- 12.10.4. Financials (Data as available in public domain and/or on paid databases)
- 12.10.5. Recent Developments
- 13. Strategic Recommendations
- 14. Appendix
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook